Market-Moving News May 2nd
Market-Moving News May 2nd
5月2日市場動向新聞
ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ovarian cancer.
ALLR：151％ | Allarity Therapeutics的股價走高，此前該公司宣佈Stenoparib顯示出明顯的臨床益處，導致晚期卵巢癌的2期試驗提前結束。
LUNG: 29% | Pulmonx shares are trading higher after the company reported better-than-expected Q1 financial results.
肺部：29％ | Pulmonx公佈的第一季度財務業績好於預期後，該公司股價走高。
EBS: 83% | Emergent Biosolutions shares are trading higher after the company announced operational changes to stabilize its financial position and reported Q1 financial results.
EBS：83% | Emergent Biosolutions的股價走高，此前該公司宣佈了運營調整以穩定其財務狀況並公佈了第一季度財務業績。